Atrial natriuretic peptide and brain natriuretic peptide in Cor pulmonale: Hemodynamic and endocrine effects

Chest

Volumn 110, Issue 5, 1996, Pages 1220-1225

  Cargill, Robert I ^a,b   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

atrial natriuretic peptide; brain natriuretic peptide; cor pulmonale; pulmonary hypertension; renin angiotensin system

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; BRONCHODILATING AGENT; DIURETIC AGENT; FUROSEMIDE; PLACEBO;

AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COR PULMONALE; DOSE RESPONSE; DRUG EFFICACY; DRUG INFUSION; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0029819945     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.5.1220     Document Type: Article

References (34)

1. Lang CC, Choy AMJ, Struthers AD. Atrial and brain natriuretic peptides: a dual natriuretic system potentially involved in circulatory homeostasis. Clin Sci 1992; 83:519-27
2. Suga S, Nakao K, Hosoda K, et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide and c-type natriuretic peptide. Endocrinology 1992; 130: 229-39
3. Lippton H, Hao Q, Hyman A. Pulmonary vasodilator properties of natriuretic peptides [abstract]. Circulation 1992; 86(suppl 1):604
4. Cargill RI, Struthers AD, Lipworth BJ. Comparative effects of ANP and BNP on the pressor and aldosterone responses to angiotensin II. Clin Sci 1995; 88:81-6
5. Gunning M, Ballerman BJ, Silva P, et al. Brain natriuretic pepride interaction with renal ANP system. Am J Physiol 1990; 258:F467-72
6. Anderson JY, Donckier J, McKenna WJ, et al. The plasma release of atrial natriuretic peptide in man. Clin Sci 1986; 71:151-55
7. Cargill RI, Coutie WJ, Lipworth BJ. The effects of angiotensin II on circulating levels of natriuretic peptides. Br J Clin Pharmacol 1994; 38:139-42
8. Struthers AD. Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? BMJ 1994; 38:139-42
9. Cody RJ, Atlas SA, Laragh JH, et al. Atrial natriuretic factor in normal subjects and heart failure patients. J Clin Invest 1986; 78:1362-74
10. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic pepride (BNP) as a novel cardiac hormone in humans. J Clin Invest 1991; 87:1402-12
11. Anand IS, Chandrashekhar Y, Ferrari R, et al. Pathogenesis of congestive state in chronic obstructive pulmonary disease. Circulation 1992; 86:12-21
12. Lang CC, Coutie WJ, Struthers AD, et al. Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease. Clin Sci 1992; 83:529-33
13. Cargill RI, Lipworth BJ. Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans. Thorax 1995; 50:183-85
14. Adnot S, Andrivet P, Chabrier PE, et al. Atrial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. J Clin Invest 1989; 83:986-93
15. Rogers TK, Sheedy W, Waterhouse J, et al. Haemodynamic effects of atrial natriuretic peptide in hypoxic chronic obstructive pulmonary disease. Thorax 1994; 49:233-39
16. Coats AJS. Doppler ultrasonic measurement of cardiac output: reproducibility and validation. Eur Heart J 1990: 11 (suppl 1): 49-61
17. Dabestani A, Mahan G, Gardin JM, et al. Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol 1987; 59:662-68
18. Beard JT, Newman JH, Loyd JE, et al. Doppler estimation of changes in pulmonary artery pressure during hypoxic breathing. J Am Soc Echocardiogr 1991; 4:121-30
19. Kitabatake A, Inoue M, Asao M, et al. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation 1983; 68:302-09
20. Brown RA, Beck JS. Comparison of several groups: the analysis of variance. In: Medical statistics on microcomputers. London: British Medical Journal Publishing, 1990; 34-42
21. Holes CA, Westphal D. Hypoxemia following the administration of sublingual nitroglycerin. Am J Med 1978; 65:911-13
22. Westendorp RGJ, Roos AN, van den Hoeven HG, et al. Atrial natriuretic peptide improves pulmonary gas exchange in subjects exposed to hypoxia. Am Rev Respir Dis 1993; 148:304-09
23. Cutaia M, Rounds S. Hypoxic pulmonary vasoconstriction: physiologic significance, mechanism and clinical relevance. Chest 1990; 97:706-18
24. Sheedy W, Stewart AG, Morice AH. ANP and BNP concentrations during intravenous saline infusion in cor pulmoanale. Thorax 1993; 48:447
25. Levin ER. Natriuretic peptide c-receptor: more than a clearance receptor. Am J Physiol 1993; 264:E483-89
26. Farber MO, Roberts LR, Weinberger MH, et al. Abnormalities of sodium and water handling in chronic obstructive lung disease. Intern Med 1982; 142:1326-30
27. Anand IS, Chandrashekhar Y, Ferrari R, et al. Pathogenesis of congestive state in chronic obstructive pulmonary disease. Circulation 1992; 86:12-21
28. Pratt RE, Dzau YJ. Trophic effects of angiotensin on blood vessels and heart. In: Robertson IS, Nicholls MG, eds. The renin angiotensin system. London: Gower Medical Publishing, 1993; 31.1-31.7
29. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest 1990; 86:1690-97
30. Magee F, Wright JL, Wiggs BR, et al. Pulmonary vascular structure and function in chronic obstructive lung disease. Thorax 1988; 43:183-89
31. Winter RJD, Zhao L, Krausz T, et al. Neutral endopeptidase 24.11 inhibition reduces pulmonary vascular remodelling in rats exposed to chronic hypoxia. Am Rev Respir Dis 1991; 144:1342-46
32. Zhao L, Hughes JMB, Winter RJD. Effects of natriuretic peptides and neutral endopeptidase 24.11 inhibition in isolated perfused rat lung. Am Rev Respir Dis 1992; 146:1198-1201
33. Lang CC, Motwani J, Coutie W, et al. Influence of candoxatril on plasma brain natiuretic peptide in heart failure. Lancet 1991; 338:255
34. Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1:681-86